Brought to you by 
Volcano Corp. buys Crux Biomedical
Jan 2013
Executive Summary
The same month it netted $445.3mm through a notes offering, Volcano Corp. has agreed to buy closely held minimally invasive cardiovascular device company Crux Biomedical Inc. for $36mm in cash, up to $3.1mm in transaction expenses, and earn-outs, including $3mm if the company gets 510(k) approval by June 30, 2013 for a retrieval device in development. Crux shareholders may receive additional cash payments based on sales (for up to four years post-commercialization).
Deal Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Full Acquisition
- Payment Includes Cash
- Includes Contract
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Volcano Corp. buys Crux Biomedical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice